Regencell Bioscience Holdings Ltd
For the period ended Jun 30, 2026. Filed Oct 7, 2026.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2026 · Filed Oct 7, 2026
RGC$5.270.0%Stored close · as of Nov 6, 2026
Opening this filing…